| 000 | 01235 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513201325.0 | ||
| 264 | 0 | _c20000217 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0041-008X | ||
| 024 | 7 |
_a10.1006/taap.1999.8817 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeresford, N | |
| 245 | 0 | 0 |
_aIssues arising when interpreting results from an in vitro assay for estrogenic activity. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cJan 2000 |
||
| 300 |
_a22-33 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aBiological Assay |
| 650 | 0 | 4 |
_aBiotransformation _xphysiology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEstrogens _xanalysis |
| 650 | 0 | 4 | _aFluorescence |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aRecombination, Genetic |
| 650 | 0 | 4 |
_aSaccharomyces cerevisiae _xgenetics |
| 650 | 0 | 4 |
_aSolvents _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aRoutledge, E J | |
| 700 | 1 | _aHarris, C A | |
| 700 | 1 | _aSumpter, J P | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 162 _gno. 1 _gp. 22-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/taap.1999.8817 _zAvailable from publisher's website |
| 999 |
_c10586577 _d10586577 |
||